Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Clinical Immunology

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study

John N. Aucott, Mark J. Soloski, Alison W. Rebman, Lauren A. Crowder, Lauren J. Lahey, Catriona A. Wagner, William H. Robinson, Kathleen T. Bechtold
R. S. Abraham, Editor
John N. Aucott
aDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Lutherville, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Soloski
aDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Lutherville, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison W. Rebman
aDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Lutherville, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren A. Crowder
bLyme Disease Research Foundation, Lutherville, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren J. Lahey
cDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA, and Veterans Affairs Palo Alto Health Care System CCSR, Palo Alto, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren J. Lahey
Catriona A. Wagner
cDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA, and Veterans Affairs Palo Alto Health Care System CCSR, Palo Alto, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William H. Robinson
cDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA, and Veterans Affairs Palo Alto Health Care System CCSR, Palo Alto, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen T. Bechtold
dDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. S. Abraham
Mayo Clinic
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00071-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/CVI.00071-16
PubMed 
27358211

Published By 
American Society for Microbiology Journals
History 
  • Received February 12, 2016
  • Returned for modification February 29, 2016
  • Accepted June 22, 2016
  • Published online September 6, 2016.

Copyright & Usage 
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers 
  • R. S. Abraham, Editor, Mayo Clinic

Article Versions

  • Accepted Manuscript version (June 29, 2016).
  • You are viewing the most recent version of this article.

Author Information

  1. John N. Aucotta,
  2. Mark J. Soloskia,
  3. Alison W. Rebmana,
  4. Lauren A. Crowderb*,
  5. Lauren J. Laheyc*,
  6. Catriona A. Wagnerc*,
  7. William H. Robinsonc and
  8. Kathleen T. Bechtoldd
  1. aDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Lutherville, Maryland, USA
  2. bLyme Disease Research Foundation, Lutherville, Maryland, USA
  3. cDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA, and Veterans Affairs Palo Alto Health Care System CCSR, Palo Alto, California, USA
  4. dDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • Address correspondence to John N. Aucott, jaucott2{at}jhmi.edu.
  • ↵* Present address: Lauren A. Crowder, American Red Cross, Rockville, Maryland, USA; Lauren J. Lahey, Biophysics Graduate Program, Stanford University School of Medicine, Stanford, California, USA; Catriona A. Wagner, Immunology Graduate Program, University of Washington Department of Immunology, Seattle, Washington, USA.

  • Citation Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT. 2016. CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study. Clin Vaccine Immunol 23:757–766. doi:10.1128/CVI.00071-16.

View Abstract

Article usage

Article usage: June 2016 to January 2021

Rendering graph...
AbstractFullPdf
Jun 20163205
Jul 2016381065
Aug 201659128
Sep 20163521533
Oct 2016145715
Nov 20168796
Dec 20164721
Jan 2017671010
Feb 20176155
Mar 2017601311
Apr 201760134
May 201737129
Jun 201728105
Jul 2017171328
Aug 2017361323
Sep 2017302716
Oct 2017402614
Nov 201734303
Dec 20172784
Jan 201844208
Feb 2018313012
Mar 201831276
Apr 2018289913
May 2018353211
Jun 201820552
Jul 201824158
Aug 201813312
Sep 20181397
Oct 20187608
Nov 201844714
Dec 2018117315
Jan 2019217011
Feb 201945732
Mar 201923710
Apr 201933419
May 2019211217
Jun 201906919
Jul 201918212
Aug 201913013
Sep 201933413
Oct 201935316
Nov 201952717
Dec 20191177
Jan 202004113
Feb 2020103719
Mar 202062714
Apr 202017269
May 20202479
Jun 202039020
Jul 202047714
Aug 202054816
Sep 202092711
Oct 2020142624
Nov 2020125020
Dec 202083230
Jan 202102512
PreviousNext
Back to top
Download PDF
Citation Tools
CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study
John N. Aucott, Mark J. Soloski, Alison W. Rebman, Lauren A. Crowder, Lauren J. Lahey, Catriona A. Wagner, William H. Robinson, Kathleen T. Bechtold
Clinical and Vaccine Immunology Sep 2016, 23 (9) 757-766; DOI: 10.1128/CVI.00071-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study
John N. Aucott, Mark J. Soloski, Alison W. Rebman, Lauren A. Crowder, Lauren J. Lahey, Catriona A. Wagner, William H. Robinson, Kathleen T. Bechtold
Clinical and Vaccine Immunology Sep 2016, 23 (9) 757-766; DOI: 10.1128/CVI.00071-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X